Vascepa is a prescription drug that contains omega-3 fatty acids and is used to treat high levels of triglycerides in the blood. Recently, the manufacturer of Vascepa, Amarin Corporation, has increased the discounts and savings available for patients who use the drug.

According to the Vascepa website [2], eligible patients can save up to $70 on their prescription, with a maximum savings of $840 per year. This is accomplished through a savings card that can be used at participating pharmacies. Additionally, the Vascepa Copay Savings Program [3] offers even more savings for eligible patients.

It is likely that these increased discounts will have a positive effect on Vascepa sales. Lower out-of-pocket costs for patients may encourage more people to try the drug, especially those who may have been hesitant due to cost concerns. Additionally, patients who are already using Vascepa may be more likely to continue using it if they are able to save money on their prescriptions.

However, it is important to note that the impact of these discounts on sales may be limited by factors such as insurance coverage and competition from other drugs. Patients may still be required to pay a significant portion of the cost of Vascepa, even with the savings card and copay program. Additionally, there are other prescription drugs available that are used to treat high triglyceride levels, which may be preferred by some patients or prescribed by their doctors instead of Vascepa.

In conclusion, the increased discounts and savings available for Vascepa may have a positive effect on sales, but the impact may be limited by other factors. Patients who are interested in trying Vascepa should consult with their doctor and insurance provider to determine the best option for their individual needs.

Sources:
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://vascepa.copaysavingsprogram.com/
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA